MP03: Bladder Cancer: Invasive I

Friday, May 13, 2022 7:00 AM to 8:15 AM · 1 hr. 15 min. (America/Chicago)
Room 222
Moderated Poster
Oncology: Bladder/Urothelium/Urethra

Information

Format
In PersonOn Demand

MP03: Bladder Cancer: Invasive I

MP03-01: Robot-Assisted Radical Cystectomy with Extracorporeal Urinary Diversion does not Increase Ureteroenteric Stricture Rate: Outcomes from a Randomized Trial comparing Open versus Robotic Cystectomy

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Benjamin Beech · MSKCC

MP03-02: Association Between Visibly Complete Transurethral Resection of Bladder Tumor and Pathologic Downstaging Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Bryce Baird · Mayo

MP03-04: Analysis of Complications after Robot-Assisted Radical Cystectomy between 2005-2020: Results from the International Robotic Cystectomy Consortium

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222

MP03-05: How does the type of urinary diversion affect health related quality of life (HRQOL) in the course of four years after radical cystectomy? - A propensity score-matched analysis

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Lennert Eismann

MP03-06: Prospective study on FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222

MP03-03: Targeting V1/Chase to overcome Gemcitabine Resistance

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Semih Sarcan · Universät zu Lübeck

MP03-07: Impact of prior intravesical bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Rikiya Taoka · Kagawa University

MP03-08: Association between ureteral clamping time and acute kidney injury during robot-assisted radical cystectomy

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Yudai Ishiyama · Tokyo Women's Medical University

MP03-09: Impact of variant histology and immunohistochemistry on response to adjuvant chemotherapy in urothelial muscle-invasive bladder cancer

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222

MP03-10: Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Francesco Chierigo · IRCCS Policlinico San Martino Hospital

MP03-11: High Expression of AHNAK2 is Associated with Biologically Aggressive Findings and Poor Survival in Patients Treated with Radical Cystectomy

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Dai Koguchi

MP03-12: Association of use of potassium competitive acid blockers and effectiveness of pembrolizumab in patients with metastatic urothelial carcinoma

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222

MP03-13: Identification of Muscle-Invasion Status in Bladder Cancer Patients Using Natural Language Processing and Machine Learning

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222

MP03-14: Neoadjuvant versus adjuvant chemotherapy in bladder cancer: A nationwide cohort study

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Jae Hun Shim

MP03-15: Primary versus Secondary Muscle Invasive Bladder Cancer: Comparing the Pathologic and Oncologic Outcomes between Both forms of Muscle Invasive Disease When Treated with Standard of Care.

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Tarik Benidir · Cleveland Clinic

MP03-16: Feasibility, Usability and Utility of a Remote Symptom Assessment Tool After Radical Cystectomy

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Heather Huelster · Moffitt Cancer Center

MP03-17: Patient, Physician, Hospital Factors Associated With Readmission After Radical Cystectomy

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Kassem Faraj

MP03-18: Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab usage: A multicenter analysis

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Teruki Isobe · Nagoya City University

MP03-19: Association between immune-related Adverse Events and Survival of Patients with metastatic Urothelial Carcinoma Treated with Pembrolizumab

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222

MP03-20: Contemporary Analysis of Cystectomy Complications

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 222
Kevin Chua